[Modality therapy of patients with non-resectable cancer using cytokines and antineoplastic agents].
Kogo
Y
Y
Niitsu
Y
Y
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D016207:Cytokines / Q000627:therapeutic use*; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage; D008297:Male; D009369:Neoplasms / Q000628:therapy*
D000970:Antineoplastic Agents; D016207:Cytokines; D007376:Interleukin-2; D016179:Granulocyte Colony-Stimulating Factor; D003520:Cyclophosphamide